Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04798664 · ClinicalTrials.gov registry record · NA
Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 3,228
- Enrollment target
NCT04798664 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 3,228 participants.
The verdict
NCT04798664, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,228 participants
- Enrollment target
Study Summary
To compare the effectiveness of four interventions to promote sustained, biochemically confirmed smoking abstinence for 6 months among underserved smokers referred for lung cancer screening at four large U.S. health systems.
Interventions
- BEHAVIORAL Financial Incentives
- BEHAVIORAL Mobile Health Application
- BEHAVIORAL Removal of Financial Barriers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,228 participants |
| Start Date | 2021-05-17 |
| Est. Completion | 2025-04-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04798664
The ClinicalTrials.gov registry entry for NCT04798664 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,228 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Financial Incentives is the first listed.
NCT04798664 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04798664 about?
NCT04798664 is a clinical study titled "Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening". To compare the effectiveness of four interventions to promote sustained, biochemically confirmed smoking abstinence for 6 months among underserved smokers referred for lung cancer screening at four large U.S. health systems.
What is the current status of trial NCT04798664?
This trial is currently completed. It is a NA study. The enrollment target is 3,228 participants. The study started on 2021-05-17. Estimated completion is 2025-04-29.
What interventions are being tested in trial NCT04798664?
The interventions under investigation include: Financial Incentives (BEHAVIORAL), Mobile Health Application (BEHAVIORAL), Removal of Financial Barriers (BEHAVIORAL).
Who is sponsoring clinical trial NCT04798664?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.